This study examined the modulatory effect of Black nightshade (Solanum nigrum L) and 
| INTRODUC TI ON
Several medicinal foods abound in traditional medicine with neuroprotective potentials that could be of importance in the management of several neurodegenerative diseases but with little or no scientific justification to substantiate their use. In the tropics, and especially in sub-Saharan Africa, green leafy vegetables are used as one of the major components of local dishes. They are desired not only for being nutritive, but also for their folkloric reports of medicinal properties. African eggplant (AE) and Black nightshade (BN) are two Solanum species that serve mainly as vegetables for soup preparation in different parts of the world. Studies have reported potential health benefits of different parts of this vegetable. Juice extracted from the leaves of AE has been reportedly used in folklore for the treatment of the Parkinson's disease, memory impairment, angina, cancerous tumor, and inflammation among others (Haliński, Paszkiewicz, Gołębiowski, & Stepnowski, 2012; Oboh, Ekperigin, & Kazeem, 2005) . BN leaves have also been reportedly used in traditional medicine for the management of several diseases including seizure and epilepsy, pain, ulcer, inflammation and diarrhea, some eye infections, and jaundice (Jain, Sharma, Gupta, Sarethy, & Gabrani, 2011) , with reports of its use in tradio-medical practices for neuromodulatory purposes but without scientific justifications.
Due to the abundance of tropane alkaloids, the potential toxicity of these vegetables to humans is warned but only when consumed at large quantities (Haliński et al., 2012; Jain et al., 2011; Sánchez-Mata, Yokoyama, Hong, & Prohens, 2010) . Considering the increas- Neurodegenerative diseases such as AD and PD are a group of chronic diseases, which are marked by systematic, selective, and continuous impairment of neuronal and cognitive functions (Martin, 1999) . Each neurodegenerative disease is classified based on its specific clinical features of disease-specific cellular biomarkers (Nieoullon, 2011) . The AD is a neurodegenerative disease with features of cognitive impairments, decline in learning and memory functions, and impairments in attention, language, and spatial coordination (Klafki, Staufenbiel, Kornhuber, & Wiltfang, 2006) . Pathophysiology of the AD includes impairments in cholinergic signaling, formation of toxic amyloid plaques, and neurofibrillary tangles in the brain, as well as oxidative neurotoxicity and inflammatory responses (Imbimbo, Lombard, & Pomara, 2005; Klafki et al., 2006) . While the etiology of AD still remains an enigma, aging and genetic predispositions have been identified as major risk factors (Imbimbo et al., 2005) . The epidemiological report has estimated the global prevalence of dementia to be up to 24 million, with a predictive doubling every 20 years until at least 2040 (Reitz, Brayne, & Mayeux, 2011) . In addition, with over seven million new cases of dementia diagnosed annually across the world (Duthey, 2013) , and as the global population ages, it is expected that the incidence of AD especially among the aged and in low-and middle-income countries will increase (Duthey, 2013; Reitz et al., 2011) . Several therapeutic drugs such as cholinesterase inhibitors have been designed for the management of AD, but their efficacy has been limited by attendant side effects (Oboh, Ogunsuyi, & Olonisola, 2017) , coupled with the often rigorous daily routine of usage. Therefore, attention is being shifted to exploring natural plant products which can offer neuroprotective properties either acting singly , or enhancing the therapeutic properties of conventional anti-Alzheimer's drugs . In this regard, green leafy vegetables with medicinal properties have shown good potentials in both in vitro Oboh et al., 2016) and in vivo studies (Baradaran, Rabiei, Rafieian, & Shirzad, 2012) .
The use of the muscarinic cholinergic receptor antagonist scopolamine to induce animal models of amnesia and cognitive dysfunctions has been widely accepted El-Khadragy, Al-Olayan, & Abdel Moneim, 2014; Marisco et al., 2013) . The ability of scopolamine to impair memory is characterized by dysfunction of the central cholinergic system of neurotransmission, impaired neuronal antioxidant status, and alteration in functional neurochemistry ElKhadragy et al., 2014; Goverdhan, Sravanthi, & Mamatha, 2012) .
This has therefore made scopolamine a useful drug in simulating human dementia and AD Kwon, Kim, Lee, & Jang, 2009; Sadek, Khan, Darras, Pockes, & Decker, 2016) .
In this study, we investigated the neuroprotective properties of African eggplant and Black nightshade by dietary inclusions (5% and 10%) of each vegetable sample in scopolamine-induced cognitive impairment in rats. The spontaneous alternation (Y-maze) test was used to evaluate the spatial working memory across various treatment groups, followed by an assessment of critical enzyme activities relevant to cognitive function in the brain tissue homogenates. We also investigated the brain nitrite level as a measure of nitric oxide content, as well as neuronal antioxidant status across various treatment groups. It is believed that findings from this study will be useful in dietary intervention and development of nutraceuticals for the management of cognitive dysfunction-associated diseases especially AD.
| MATERIAL S AND ME THODS

| Materials
| Collection and preparation of samples
African eggplant (Solanum marcrocarpon L) and Black nightshade (Solanum nigrum L) vegetables were purchased from local market in Ede, Osun State, Nigeria. Authentication of the samples was carried out at the Department of Biology, Federal University of Technology, Akure, Ondo State, Nigeria. The leaves were washed with water and chopped into small pieces, dried under shade, and milled into a fine powder using stainless steel electric blender. The pulverized samples were subsequently used for feed formulation.
| Chemicals and reagents
Chemicals and reagents used such as semicarbazide, benzylamine, acetylthiocholine iodide, and scopolamine were procured from Sigma-Aldrich, Inc. (St Louis, MO); trichloroacetic acid (TCA) was sourced from Sigma-Aldrich, Chemie GmbH (Steinheim, Germany); 2,4-dinitrophenyl hydrazine (DNPH) from ACROS Organics (New Jersey, USA), methanol and acetic acid were sourced from BDH Chemicals Ltd. (Poole, England). All other chemicals were of analytical grade, while the water used for all analysis was glass distilled.
| Methods
| Experimental animals
Albino rats weighing 150-200 g were used for this study. Rats were maintained at 25°C, on a 12-hr light/12-hr dark cycle. They were acclimatized under these conditions for 1-2 weeks before the experiment. The rats were allowed free access to food and water ad libitum. All applicable international, national, and/or institutional guidelines for the care and use of laboratory animals were followed.
| Experimental design
After a period of 2-week acclimatization, the rats were randomly divided into seven groups (n = 4). Groups 1-III were fed basal diets, and groups IV and V were fed diets supplemented with 5% and 10% Black nightshade (BN) leaf inclusions, respectively, while groups VI and VII were fed diets supplemented with 5% and 10% African eggplant (AE) leaf inclusions, respectively, for 14 days. Animals in groups II-VII were administered scopolamine hydrobromide (2 mg/kg body weight; i.p) 30 min. to behavioral test (Sadek et al., 2016) and animals in group III serve as the positive control and were administered 5 mg/kg body weight (p.o.) of donepezil hydrochloride (Kamat et al., 2011) once before administration of scopolamine (see Figure 1 for the experimental protocol scheme).
| Feed formulation, sample inclusion, and treatment groups
Freshly formulated diets were prepared using the method reported by Ademiluyi, Oboh, Ogunsuyi, and Akinyemi (2012) . All formulated feeds were kept in airtight containers at 4°C. Rats' feeding per group includes the following:
Group 1: Normal control rats fed with basal diet (50% skimmed milk, 36% corn starch, 10% groundnut oil, and 4% vitamin and mineral premix).
Group II: Scopolamine-administered (2 mg/kg body weight; i.p) rats fed with basal diet.
Group III: Positive control-Scopolamine-administered rats fed with basal diet and administered donepezil (5 mg/kg body weight; p.o.).
Group IV: Scopolamine-administered (2 mg/kg body weight) rats fed with diet supplemented with 5% Black nightshade leaves.
Group V: Scopolamine-administered (2 mg/kg body weight) rats fed with diet supplemented with 10% Black nightshade leaves.
Group VI: Scopolamine-administered (2 mg/kg body weight) rats fed with diet supplemented with 5% African eggplant leaves.
Group VII: Scopolamine-administered (2 mg/kg body weight) rats fed with diet supplemented with 10% African eggplant leaves. Inclusions of AE and BN leaves were at equivalent weight basis. 
| Y-maze (spontaneous alternation) test
This was carried out to analyze the spatial working memory of the animals. The Y-maze test was performed according to a previously described method . The maze was made of three identical arms, 40 cm long, 35 cm high, and 12 cm wide, positioned at equal angles and labeled A, B, and C. Rats were placed at the end of one arm and allowed to move freely through the maze during a 5-min session. Spontaneous alternation was examined by visually recording the pattern of entrance into each arm in the maze for each rat. An arm entry was considered to be complete when the hind paws of the rat were completely placed on the arm. Alternation was defined as successive entries into the three arms on the overlapping triplet set (i.e., ABC, BCA…).
Accordingly, the frequencies of alteration between the arms recorded were plotted to determine the memory index (percentage of correct alteration).
| Bioassays
| Preparation of brain tissue homogenate
At the completion of Y-maze test, the rats were immobilized by cervical dislocation and the whole-brain tissues were rapidly isolated, rinsed with cold saline, placed on ice, and weighed. These tissues were subsequently homogenized in appropriate buffer 362; Aayu-shi Design Pvt. Ltd. India). The homogenates were centrifuged for 10 min at 3,000×g in a refrigerated centrifuge (KX3400C; KENXIN Intl. Co., Hong Kong) at 4°C to yield pellets that were discarded, and supernatants (homogenates), which were used for all bioassays. 
| Determination of cholinesterases (ChEs) activity
| Determination of monoamine oxidase activity
The activity of monoamine oxidase (MAO) was assayed according to a previously reported method (Green & Haughton, 1961) with slight modifications. In brief, the reaction mixture contained 0.025 mol/L phosphate buffer (pH 7.0), 0.0125 mol/L semicarbazide, 10 mmol/L benzylamine, and 100 μl of tissue homogenate. After 30-min incubation, acetic acid was added and incubated for 3 min in boiling water bath followed by centrifugation. The resulting supernatant (1 ml) was mixed with equal volume of 2, 4-Dinitrophenylhydrazine, and 1.25 ml of benzene was added after 10-min incubation at room temperature. After separating the benzene layer, it was mixed with equal volume of 0.1 N NaOH. The alkaline layer was decanted and incubated at 80°C for 10 min. The orange-yellow color developed was measured at 450 nm in a UV/visible spectrophotometer (Jenway 6305 model).
| Determination of arginase activity
Arginase activity in the brain homogenate was determined by the method of Kaysen and Strecker (1973) . In brief, the tissue homogenate (75 μl) was pre-incubated for 5 min in a solution of 0.05 mmol/L Manganese chloride in 0.01 mmol/L Tris-HCl buffer (pH 7.5). Thereafter, the reaction was initiated by adding the reaction substrate (50 mmol/L L-arginine) followed by incubation at 37°C for 10 min. The reaction was terminated by adding 2.5 ml of Ehrlich's reagent (p-dimethylaminobenzaldehyde in 3.6 N HCl).
The amount of urea produced was measured spectrophotometrically at 450 nm, normalized with protein, and used as an index for arginase activity.
| Estimation of nitrite level
Assay for brain nitrite level was carried out as an indicator of the amount of nitric oxide (NO) by a spectrophotometric assay using Griess reagent (0.1% N-(1-naphthyl) ethylenediamine dihydrochloride, 1% sulfanilamide, and 2.5% phosphoric acid) (Green et al., 1982) . Equal volumes of tissue homogenate and Griess reagent were mixed, the mixture was incubated for 10 min at room temperature in the dark, and the absorbance was determined at 540 nm spectrophotometrically. The concentration of nitrite in the supernatant was determined from the sodium nitrite standard curve and expressed as μmol/mg protein.
| Lipid peroxidation assay
The lipid peroxidation assay was carried out according to the modified method of Ohakawa, Ohishi, and Yagi (1979) . Briefly, 300 ml of the brain homogenate was added to 300 ml of 8.1% sodium dodecyl sulfate (SDS), 500 ml of acetic acid/HCl buffer (pH 3.4), and 500 ml of 0.8% thiobarbituric acid (TBA). This mixture was incubated at 100°C for 1 hr, and thiobarbituric acid reactive species (TBARS) produced were measured at 532 nm using a spectrophotometer.
Malondialdehyde (MDA) was used as standard, and TBARS produced was reported as MDA equivalent.
| Antioxidant enzyme assays
Glutathione-S-transferase (GST) activity was assayed according to the method of Habig, Pabst, and Jakoby (1974) The absorbance was read at 412 nm in a spectrophotometer. Total protein was measured according to Bradford (1976) using serum albumin as standard.
| Data analysis
Results were expressed as the mean ± standard deviation (SD). Mean values were appropriately analyzed and compared using one-way analysis of variance (ANOVA) followed by Newman-Keuls multiple range post hoc test; significance was accepted at p < .05; p < .01; p < .001. All statistical analysis was carried out using GraphPad Prism version 5.00 for Windows.
| RE SULT
Investigations in this study commenced by assessing the ef- , 2016) . Previous findings have shown that SCOP can induce an elevation in rats' AChE activity, thereby mimicking the pathophysiology of many neurodegenerative diseases (Gutierres et al., 2010; Xian et al., 2015) . The ability of dietary inclusions of AE and BN leaves to reverse the SCOP-induced elevation in ChEs activities in experimental rats could be as a result of their constituent phytochemicals. It has been previously reported that AE leaves are rich in phytochemicals such as alkaloids, sapogenins, and sterols (Gbile & Adesina, 1988 ).
| D ISCUSS I ON
The plant is specifically known to be rich in glycoalkaloids especially solasodine which has been reported to promote neurogenesis (Patel, Singh, & Patel, 2013) . Similarly, BN is specifically known to be rich in two alkaloids, solamargine and solasonine: the precursors of glycine solasodine which is of numerous pharmacologically importance . Previous studies have correlated reduced cholinesterase activity with impaired learning and memory functions in different rat models (Adeniyi, Omatsuli, Akinyemi, & Ishola, 2016; Akinyemi et al., 2017; Rubio et al., 2017) . In this study, we showed that scopolamine significantly reduced the spatial working memory of rats measured via the Y-maze test. This agrees with previous reports that scopolamine induces cognitive deficiencies in animals Kwon et al., 2009; Soni & Parle, 2017) . The Y-maze test is an experimental behavioral procedure widely used to assess immediate spatial working memory, which is one of the indices of overall cognitive function (de Bruin et al., 2010; Hamlin, Windels, Boskovic, Sah, & Coulson, 2013) . Therefore, the ability of pretreated AE and BN dietary inclusions to prevent SCOP-induced impaired spatial working memory could be correlated with their anti-ChEs activities.
Furthermore, it was observed in this study that dietary inclusions of AE and BN leaves (5% and 10%) significantly reversed the elevation of MAO activity in SCOP-induced amnesic rats. It is noteworthy that previous reports show no significant effect of SCOP on brain MAO activity (Bihaqi, Singh, & Tiwari, 2011; Liu et al., 2017; Rubio et al., 2017) ; we, however, observed that these studies reported administration of 1 mg/kg SCOP. Nevertheless, El-Khadragy et al. (2014) reported significant alterations in brain monoamines in rats administered 1.4 mg/kg SCOP. Thus, we hypothesize that the significant reduction in MAO activity induced by SCOP in this study could be as a result of the higher dose used (2 mg/kg). It has been reported that impairment of the monoaminergic system of neurotransmission resulting from elevated MAO activity contributes significantly to the pathogenesis and progression of several neurodegenerative diseases including AD and PD (Kaludercic, Carpi, Menabò, Di Lisa, & Paolocci, 2011; Nwanna et al., 2016) .
Elevation in MAO activity results in the rapid breakdown of both inhibitory and excitatory monoamine neurotransmitters such as adrenaline, dopamine, and serotonin, which are crucial in anxiety and mood disorders Thomas, 2000) . Therefore, in the clinical management of several neurodegenerative diseases, especially AD and PD, MAO inhibitors are often useful therapies, especially as antidepressants (Baker, Matveychuk, MacKenzie, Dursun, & Mousseau, 2012; Oboh et al., 2016; Thomas, 2000; Yu, Kong, & Chen, 2002) . Furthermore, several experimental studies have shown that plant extracts such as phenolic-rich and alkaloidrich extracts elicited significant MAO inhibitory effects in both in vitro (Ademiluyi et al., 2016; Nwanna et al., 2016) and in vivo (Yu et al., 2002) studies. Therefore, the ability of dietary inclusions of AE and BN leaves to reverse elevation in MAO activities in SCOPinduced amnesic rats could also be attributed to the constituent phytochemicals in the vegetable with bioactive properties. We quantified the brain nitrite level in this study as a measure of the nitric oxide (NO) content. In agreement with earlier studies (El-Khadragy et al., 2014; Giridharan, Thandavarayan, Sato, Ko, & Konishi, 2011) , we observed that SCOP caused a significant elevation in brain NO content. NO can serve as a neurotransmitter that mediates synaptic activity, neural plasticity, and memory functions (Pitsikas, 2015) . Furthermore, NO has been shown to influence presynaptic cellular transmission processes and promotes synaptic plasticity (Pitsikas, 2015) . Behavioral studies have reported that inhibition of nitric oxide synthase (NOS), which synthesizes NO, impairs learning and such deficiencies could be attenuated by NO donors (Paul & Ekambaram, 2011) . Therefore, the ability of dietary inclusions of AE and BN to reverse the elevation in NO content induced by SCOP is also noteworthy and could be another neuroprotective mechanism. This is more so because the neuronal actions of NO are concentration dependent, with low concentrations eliciting neuroprotective properties and mediating neurotransmission, while higher concentrations are involved in immune responses and inflammatory actions, and are considered neurotoxic (Calabrese et al., 2007; Pitsikas, 2015) . In addition, the ability of BN and AE to prevent NO depletion could also justify the improved cognitive function in treated rats. This is so because a connection has been established between depletion of a neuronal NO through inhibition of its synthesis, reduction in acetylcholine release, and impairment in conditional responses in rats (Paul & Ekambaram, 2011) .
Oxidative stress is one of the major risk factors for the pathogenesis and progression of several neurodegenerative diseases, through mechanisms such as free radical-induced mitochondrial dysfunction and neuronal cell death (Bhat et al., 2015; Lin & Beal, 2006; Shukla, Mishra, & Pant, 2011) . Furthermore, elevation in MAO activities has been linked to free radical-induced oxidative stress. This is because hydrogen peroxide (H 2 O 2 ) is one of the by-products of MAO hydrolysis of biogenic amines (Cadenas & Davies, 2000) . In the presence of Fe there was a significant elevation in brain GSH contents, which was observed to be reduced significantly in SCOP-treated rats. Similarly, SCOP-induced rats pretreated with dietary inclusions of AE and AN also exhibited elevated activities of GST and SOD which were reduced significantly in SCOP-induced rats. GSH is a ubiquitous endogenous antioxidant molecule that functions to stabilize free radicals by serving as proton donors, particularly against hydroxyl (OH) radicals (Bains & Shaw, 1997) . Previous studies have shown an age-related decline in GSH to be a key factor in the aging process which could contribute to several changes observed in the normal aging process as well as in the pathogenesis of various diseases (Bains & Shaw, 1997) . On the other hand, GST functions to conjugate GSH to xenobiotics for the purpose of detoxification (Sofia, Segura-Aguilar, Widersten, Johansson, & Mannervik, 1997) .
Therefore, the increase in GST activity in SCOP-induced rats pretreated with dietary inclusions of AE and BN (5% and 10%) could be another mechanism by which AE and BN help overcome SCOPinduced neurotoxicity by increasing the activity of GST detoxifying enzyme. The ability of dietary inclusions of AE and AN (5% and 10%) to significantly reverse the reduction in both GSH contents and GST and SOD activities in SCOP-induced rats could therefore contribute significantly to the neuroprotective properties of these vegetables.
| CON CLUS ION
The ability of dietary inclusions of African eggplant (Solanum marcrocarpon L) and Black nightshade (S. nigrum L) leaves in ameliorating scopolamine-induced cognitive impairment in rats was reported in this study. Scopolamine-administered rats pretreated with dietary inclusions of African eggplant and Black nightshade leaves (5% and 10%) were able to significantly reverse the impairments in critical enzymes of the cholinergic (AChE and BChE) and monoaminergic (MAO) systems, as well as the antioxidant system induced by scopolamine. These therapeutic properties could be attributed to the constituent phytochemicals in the vegetable. Therefore, this study has provided some scientific rationale for these vegetables in the management of neurodegenerative diseases as obtained in folklore. Hence Therefore, these vegetables could serve as a potential source of functional foods and nutraceuticals for the prevention and management of neurodegenerative diseases, especially AD.
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